Path ID: DB06255_MESH_D010024_1

db06255-mesh-d010024-1

Concepts

Identifier Name Type
MESH:C071542 incadronic acid Drug
UniProt:P14324 Farnesyl pyrophosphate synthase Protein
GO:0008299 isoprenoid biosynthetic process BiologicalProcess
GO:0045453 bone resorption BiologicalProcess
HP:0004349 Reduced bone mineral density PhenotypicFeature
CHEBI:52255 hydroxylapatite ChemicalSubstance
GO:0006915 apoptotic process BiologicalProcess
CL:0000092 osteoclast Cell
GO:0001503 ossification BiologicalProcess
GO:1990523 bone regeneration BiologicalProcess
MESH:D010024 Osteoporosis Disease

Relationships

NOTE: predicates are annotated in Biolink Model (v1.3.0)

Subject Predicate Object
Incadronic Acid DECREASES ACTIVITY OF Farnesyl Pyrophosphate Synthase
Farnesyl Pyrophosphate Synthase POSITIVELY REGULATES Isoprenoid Biosynthetic Process
Isoprenoid Biosynthetic Process POSITIVELY CORRELATED WITH Bone Resorption
Bone Resorption POSITIVELY CORRELATED WITH Reduced Bone Mineral Density
Reduced Bone Mineral Density MANIFESTATION OF Osteoporosis
Incadronic Acid POSITIVELY REGULATES Apoptotic Process
Apoptotic Process DECREASES ABUNDANCE OF Osteoclast
Osteoclast POSITIVELY REGULATES Bone Resorption
Incadronic Acid MOLECULARLY INTERACTS WITH Hydroxylapatite
Hydroxylapatite POSITIVELY CORRELATED WITH Ossification
Hydroxylapatite POSITIVELY CORRELATED WITH Bone Regeneration
Bone Regeneration NEGATIVELY CORRELATED WITH Osteoporosis
Ossification NEGATIVELY CORRELATED WITH Osteoporosis

Reference: